Successes and failures of current treatment of heart failure

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165

Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725

Beta blockade during and after myocardial infarction: An overview of the randomized trials

Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205

The effect of digoxin on mortality and morbidity in patients with heart failure

(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214

Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay

Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C. M., Garrigue, S., KAPPENBERGER, L. J., Haywood, G. A., Santini, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441202 · Cited by 2,718

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

Troughton, R. W., FRAMPTON, C. M. A., Yandle, T. G., Espine, E. A., Nicholls, M. G., & Richards, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02060-2 · Cited by 1,358

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca 2+ -ATPase in Patients With Advanced Heart Failure

Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760

Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block

Nelson, G. S., Berger, R. D., Fetics, B. J., Talbot, M. W., Spinelli, J., Hare, J. M., & Kass, D. A. (2000) · Circulation · doi:10.1161/01.cir.102.25.3053 · Cited by 759

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey

Cleland, J. G. F., Solal, A. C., Aguilar, J. A. C., Dietz, R., Eastaugh, J., Folláth, F., Freemantle, N., Gavazzi, A., van Gilst, W. H., Hobbs, R. F., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11601-1 · Cited by 533

Cardiovascular prevention and blood pressure reduction

Staessen, J. A., Wang, J., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00002 · Cited by 483

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial

Jaski, B. E., Jessup, M. L., Mancini, D. M., Cappola, T. P., Pauly, D. F., Greenberg, B., Borow, K., Dittrich, H., Zsebo, K. M., & Hajjar, R. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.013 · Cited by 457

The relationship between cholesterol and survival in patients with chronic heart failure

Rauchhaus, M., Clark, A. L., Doehner, W., Davos, C. H., Bolger, A. P., Sharma, R. K., Coats, A. J. S., & Anker, S. D. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.016 · Cited by 444

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

Lenzen, M. J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.006 · Cited by 369

The heart failure epidemic: exactly how big is it?

Cleland, J. G. F. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2493 · Cited by 330

Persistently Increased Serum Concentrations of Cardiac Troponin T in Patients With Idiopathic Dilated Cardiomyopathy Are Predictive of Adverse Outcomes

Sato, Y., Yamada, T., Taniguchi, R., Nagai, K., Makiyama, T., Okada, H., Kataoka, K., Ito, H., Matsumori, A., Sasayama, S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.369 · Cited by 308

The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure

Witte, K. K., Nikitin, N. P., Parker, A. C., von Haehling, S., Volk, H., Anker, S. D., Clark, A. L., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi442 · Cited by 298

The Crucial Role of Patient Education in Heart Failure

Strömberg, A. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.002 · Cited by 265

Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF Study

Cleland, J. G. F., Tendera, M., Adamus, J., Freemantle, N., Gray, C. S., Lye, M., O’Mahony, D., Poloński, L., & Taylor, J. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00039-2 · Cited by 254

Blood Pressure Reduction and Cardiovascular Prevention: An Update Including the 2003-2004 Secondary Prevention Trials

Staessen, J. A., Li, Y., Thijs, L., & Wang, J. (2005) · Hypertension Research · doi:10.1291/hypres.28.385 · Cited by 246

Is the Prognosis of Heart Failure Improving?

Cleland, J. G. F., Gemmell, I., Khand, A. U., & Boddy, A. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00032-x · Cited by 241

Chronic heart failure and micronutrients

Witte, K. K., Clark, A. L., & Cleland, J. G. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01227-x · Cited by 237

Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation

Molhoek, S. G., Bax, J. J., Bleeker, G. B., Boersma, E. H., van Erven, L., Paul Steendijk, A., van der Wall, E. E., & Schalij, M. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.028 · Cited by 208

Diastolic heart failure: neglected or misdiagnosed?

Banerjee, P., Banerjee, T., Khand, A. U., Clark, A. L., & Cleland, J. G. F. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01704-1 · Cited by 180

Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera

Jung, H. A., Hyun, S. K., Kim, H. R., & Choi, J. S. (2006) · Fisheries Science · doi:10.1111/j.1444-2906.2006.01288.x · Cited by 175

Estrogenic hormone action in the heart: regulatory network and function

Babiker, F. A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00526-0 · Cited by 171

The Euro Heart Failure Survey of The EUROHEART Survey Programme: A Survey on the Quality of Care Among Patients with Heart Failure in Europe

Cleland, J. G. F., Swedberg, K. B., Solal, A. C., Cosín‐Aguilar, J., Dietz, R., Folláth, F., Gavazzi, A., Hobbs, R. F., Korewicki, J., Madeira, H. C., et al. (2000) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00081-7 · Cited by 153

β-ADRENERGIC RECEPTORS AND RECEPTOR SIGNALING IN HEART FAILURE

Post, S. R., Hammond, H. K., & Insel, P. A. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.343 · Cited by 153

Management of heart failure among very old persons living in long-term care: Has the voice of trials spread?

Gambassi, G., Forman, D. E., Lapane, K. L., Mor, V., Sgadari, A., Lipsitz, L. A., & Bernabei, R. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90313-2 · Cited by 121

Which patients with heart failure respond best to multidisciplinary disease management?

Riegel, B. J., Carlson, B., Glaser, D. N., & Hoagland, P. M. (2000) · Journal of Cardiac Failure · doi:10.1054/jcaf.2000.19226 · Cited by 111

Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure

Goto, T., Takase, H., Toriyama, T., Sugiura, T., Sato, K., Ueda, R., & Dohi, Y. (2003) · Heart · doi:10.1136/heart.89.11.1303 · Cited by 110

The evidence for beta blockers in heart failure

Cleland, J. G. F., McGowan, J., Clark, A. L., & Freemantle, N. (1999) · BMJ · doi:10.1136/bmj.318.7187.824 · Cited by 107

Effects of Angiotensin-Converting Enzyme Inhibitors and Digoxin on Health Outcomes of Very Old Patients With Heart Failure

Gambassi, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.53 · Cited by 103

Antioxidative and ACE inhibitory activities of protein hydrolysates from the muscle of brownstripe red snapper prepared using pyloric caeca and commercial proteases

Khantaphant, S., Benjakul, S., & Kishimura, H. (2010) · Process Biochemistry · doi:10.1016/j.procbio.2010.09.005 · Cited by 102

Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial

Hutcheon, S., Gillespie, N. D., Crombie, I. K., Struthers, A. D., & McMurdo, M. E. T. (2002) · Heart · doi:10.1136/heart.88.4.373 · Cited by 101

Elimination of Early Rehospitalization in a Randomized, Controlled Trial of Multidisciplinary Care in a High-Risk, Elderly Heart Failure Population: The Potential Contributions of Specialist Care, Clinical Stability and Optimal Angiotensin-Converting Enzyme Inhibitor Dose at Discharge

McDonald, K., Ledwidge, M. T., Cahill, J., Kelly, J., Quigley, P. J., MAURER, B. J., Begley, F., Ryder, M., Travers, B., Timmons, L., et al. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(00)00134-3 · Cited by 95

Sudden Death in Heart Failure: Vascular or Electrical?

Cleland, J. G. F., Massie, B. M., & Packer, M. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00009-4 · Cited by 92

Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure

Braunschweig, F. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2690 · Cited by 87

Coenzyme Q10: is there a clinical role and a case for measurement?

Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87

Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure

Bettencourt, P., Friões, F., Azevedo, A., Dias, P., Pimenta, J. M., Rocha‐Gonçalves, F., & Ferreira, A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(03)00115-3 · Cited by 84

An ethnographic approach to understanding the illness experiences of patients with congestive heart failure and their family members

Mahoney, J. S. (2001) · Heart & Lung · doi:10.1067/mhl.2001.119832 · Cited by 78

Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review

Otaki, Y., Watanabe, T., & Kubota, I. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.09.007 · Cited by 70

Prioritizing symptom management in the treatment of chronic heart failure

Koshy, A. O., Gallivan, E. R., McGinlay, M., Straw, S., Drozd, M., Toms, A. G., Gierula, J., Cubbon, R. M., Kearney, M. T., & Witte, K. K. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12875 · Cited by 66

Persistently Increased Serum Concentration of Heart-Type Fatty Acid-Binding Protein Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure

Niizeki, T., Takeishi, Y., Arimoto, T., Nozaki, N., Hirono, O., Watanabe, T., Nitobe, J., Miyashita, T., Miyamoto, T., Koyama, Y., et al. (2007) · Circulation Journal · doi:10.1253/circj.72.109 · Cited by 67

The Role of Estrogen in Cardiac Metabolism and Diastolic Function

Li, S., & Gupte, A. A. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-1-4 · Cited by 65

Circulating Levels of Myocardial Proteins Predict Future Deterioration of Congestive Heart Failure

Sugiura, T., Takase, H., Toriyama, T., Goto, T., Ueda, R., & Dohi, Y. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.04.025 · Cited by 65

Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study

Cleland, J. G. F. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2570 · Cited by 60

Inhibitory Activities of Cassia tora and its Anthraquinone Constituents on Angiotensin‐Converting Enzyme

Hyun, S. K., Lee, H., Kang, S. S., Chung, H. Y., & Choi, J. S. (2008) · Phytotherapy Research · doi:10.1002/ptr.2579 · Cited by 59

Has the survival of the heart failure population changed? lessons from trials

Cleland, J. G. F., & Clark, A. L. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01011-x · Cited by 52

Atrial Fibrillation Burden During the Post‐Implant Period After CRT Using Device‐Based Diagnostics

Hügl, B. J., BRUNS, H., UNTERBERG‐BUCHWALD, C., Große, A., Stegemann, B., Lauer, B., Geller, J. C., & Gasparini, M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00482.x · Cited by 51

Risk of cardiovascular death in elderly patients with possible heart failure

Alehagen, U., Lindstedt, G., Levin, L., & Dahlström, U. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.006 · Cited by 47

Outcome Studies with Device Therapy in Patients with Heart Failure

Cleland, J. G. F., Thackray, S. D. R., GOODGE, L., Kaye, G., & Cooklin, M. (2002) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2002.tb01958.x · Cited by 47

Long‐Term Follow‐Up of Cardiac Resynchronization Therapy in Patients with End‐Stage Heart Failure

Molhoek, S. G., Bax, J. J., Bleeker, G. B., Holman, E. R., ERVEN, L. V., Bootsma, M., Boersma, E. H., Paul Steendijk, A., van der Wall, E. E., & Schalij, M. J. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40685.x · Cited by 46

Increasing Awareness and Improving the Management of Heart Failure in Europe: The IMPROVEMENT of HF Initiative

The Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00021-5 · Cited by 43

Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives

Witte, K. K., & Clark, A. L. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9194-4 · Cited by 42

RecurrentNF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1)

Buske, A., Gewies, A., Lehmann, R., R�ther, K., Algermissen, B., N�rnberg, P., & Tinschert, S. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991008)86:4 · Cited by 15

Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure

Lowrie, R., Johansson, L., Forsyth, P., Bryce, S. L., McKellar, S., & Fitzgerald, N. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9889-2 · Cited by 41

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)

Baruch, L., Glazer, R. D., Aknay, N., Vanhaecke, J., Heywood, J. T., Anand, I. S., Krum, H., Hester, A., & Cohn, J. N. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.06.001 · Cited by 38

Recent advances in cardiac hypertrophy

Olivetti, G. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00298-9 · Cited by 39

Trends and predictors of hospitalization, readmissions and length of stay in ambulatory patients with heart failure

Capell, E. F., Colet, J. C., Miralles, J. D., Gich, I. J., Wensing, M., & Verdú-Rotellar, J. M. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.10.006 · Cited by 38

Cholesterol — A marker of nutritional status in mild to moderate heart failure

Araújo, J. P., Friões, F., Azevedo, A., Lourenço, P., Rocha‐Gonçalves, F., Ferreira, A., & Bettencourt, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.05.026 · Cited by 38

Endothelin antagonists for chronic heart failure: do they have a role?

Cowburn, P. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2557 · Cited by 38

Aetiology, Comorbidity and Drug Therapy of Chronic Heart Failure in the Real World: The EPICA Substudy

Ceia, F., Fonseca, C., Mota, T., Morais, H., Matias, F., Costa, C., & Oliveira, A. G. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.09.003 · Cited by 37

Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure

Movsesian, M. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.963 · Cited by 37

Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium

Karlsson, J., Brurok, H., Eriksen, M., Towart, R., Toft, K. G., Moen, O., Engebretsen, B. J., Jynge, P., & Refsum, H. (2001) · Acta Radiologica · doi:10.1034/j.1600-0455.2001.420602.x · Cited by 30

Estudio europeo del tratamiento ambulatorio de la insuficiencia cardíaca realizado por cardiólogos

Salvador, M. J., Sebaoun, A., Sonntag, F., Blanch, P., Silber, S., Aznar, J., & Michel Komajda, N. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77259-0 · Cited by 26

Coenzyme Q10; an adjunctive therapy for congestive heart failure?

Molyneux, S. L., Florkowski, C. M., Richards, M., Lever, M., Young, J. M., & George, P. M. (2009) · PubMed · Cited by 24

Atriobiventricular pacing improves exercise capacity in patients with heart failure and intraventricular conduction delay

Varma, C., Sharma, S., Firoozi, S., McKenna, W. J., & Daubert, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02849-8 · Cited by 22

What is the optimal medical management of ischemic heart failure?

Cleland, J. G. F., Alamgir, F. M., Nikitin, N. P., Clark, A. L., & Norell, M. S. (2001) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2001.20670 · Cited by 22

Discharge treatment with angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

Vicent, L., Juan Cinca, A., Vázquez, R., González‐Juanatey, J. R., Rivera, M., Segovia, J., Pascual-Figal, D. A., Bover, R., Worner, F., Delgado, J. F., et al. (2019) · Internal Medicine Journal · doi:10.1111/imj.14289 · Cited by 21

A community model of group rehabilitation for older patients with chronic heart failure: A pilot study

Hui, E., Yang, H. M., Chan, L. S., Or, K. H., Lee, D., Yu, C., & Woo, J. (2006) · Disability and Rehabilitation · doi:10.1080/09638280600646219 · Cited by 21

A survey of outpatient management of elderly heart failure patients in Poland—treatment patterns

Rywik, T. M., Rywik, S. L., Korewicki, J., Broda, G., Sarnecka, A., & Drewla, J. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.04.027 · Cited by 21

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

Saxon, L. A., & Marco, T. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01638-2 · Cited by 21

Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches

Koniari, K., Parissis, J., PARASKEVAIDIS, I. A., & ANASTASIOU‐NANA, M. I. (2012) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872612457044 · Cited by 20

Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction

Kraaij, D. J. W. V., Jansen, R. W. M. M., Gribnau, F. W. J., & Hoefnagels, W. H. L. (2000) · Drugs & Aging · doi:10.2165/00002512-200016040-00005 · Cited by 20

Inappropriate use of loop diuretics in elderly patients

Kelly, J. (2000) · Age and Ageing · doi:10.1093/ageing/29.6.489 · Cited by 20

The Cardiac Insufficiency Bisoprolol Study II

Poole-Wilson, P. A. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74354-3 · Cited by 20

Contemporary management of heart failure in clinical practice

Cleland, J. G. F. (2002) · Heart · doi:10.1136/heart.88.suppl_2.ii5 · Cited by 19

Review. The electrocardiogram in heart failure

Kelly, J. (2000) · Age and Ageing · doi:10.1093/ageing/29.3.203 · Cited by 19

European Study of Ambulatory Management of Heart Failure by Cardiologists

Salvador, M. J., Sebaoun, A., Sonntag, F., Blanch, P., Silber, S., Aznar, J., & Michel Komajda, N. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60209-0 · Cited by 19

The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population

Alehagen, U., Lindstedt, G., Levin, L., & Dahlström, U. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.03.031 · Cited by 18

RESICARD: East Paris network for the management of heart failure: Absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation

Assyag, P., Renaud, T., Solal, A. C., Viaud, M., Krys, H., Bundalo, A., Michel, P.-L., Boukobza, R., Bourgueil, Y., & Cohen, A. A. (2009) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.10.013 · Cited by 17

Carvedilol for Heart Failure: Clinical Trials in Progress

McGowan, J., Murphy, R. L. W., & Cleland, J. G. F. (1999) · Heart Failure Reviews · doi:10.1023/a:1009812019524 · Cited by 16

Implantable cardioverter defibrillators for prevention of sudden cardiac Death

Sukhija, R., Mehta, V., Leonardi, M., & Mehta, J. L. (2007) · Clinical Cardiology · doi:10.1002/clc.20001 · Cited by 14

ICD lead implantation via persistent left superior vena cava

Yasuda, M., Nakazato, Y., & Daida, H. (2003) · Heart · doi:10.1136/heart.89.11.1307 · Cited by 11

Carvedilol: something else than a simple betablocker?

Palazzuoli, A., Calabria, P., Verzuri, M. S., & Auteri, A. (2002) · PubMed · Cited by 11

Effect of nolomirole on monocrotaline-induced heart failure

Pasini, E., Anna, C., Pastore, F., Razzetti, R., Bongrani, S., Luca, G. G., & Ferrari, R. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00246-9 · Cited by 11

Angiotensin converting enzyme inhibitory benzopyranoids from Angelica gigas

Hyun, S. K., Oh, Y. N., Kwon, H. J., & Kim, B. W. (2013) · Food Science and Biotechnology · doi:10.1007/s10068-013-0275-6 · Cited by 10

Fish oils – adjuvant therapy in chronic heart failure?

Witte, K. K., & Clark, A. L. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000136728.27524.f5 · Cited by 10

Digitalis inhibits and furosemide does not change the in vitro phagocytic function of neutrophils of healthy subjects

Muniz‐Junqueira, M. I. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00142-5 · Cited by 10

Heart Failure Management Programmes: Delivering the Message

Dickstein, K., & Jaarsma, T. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.01.006 · Cited by 9

What is the optimal medical management of ischaemic heart failure?

Cleland, J. G. F., John, J., Dhawan, J., & Clark, A. L. (2001) · British Medical Bulletin · doi:10.1093/bmb/59.1.135 · Cited by 9

Impact of Different Pacing Modes on Left Ventricular Contractility Following Cardiopulmonary Bypass

Bakhtiary, F., DOGAN, S., Dzemali, O., Ackermann, H., Kleine, P., Schächinger, V., Moritz, A., & Aybek, T. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00817.x · Cited by 9

Neurohormones and heart failure

Mendzef, S. D., & Slovinski, J. R. (2004) · Nursing Clinics of North America · doi:10.1016/j.cnur.2004.07.004 · Cited by 8

Angiotensin-converting enzyme inhibitory activity of Senna garrettiana active compounds: Potential markers for standardized herbal medicines

Charoonratana, T., & Madaka, F. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_325_17 · Cited by 8

Reduction in hospitalization rates following cardiac resynchronisation therapy in cardiac failure: experience from a single centre

Dixon, L., Murtagh, J., RICHARDSON, S., & Chew, E. W. (2004) · EP Europace · doi:10.1016/j.eupc.2004.08.006 · Cited by 8

Pharmacological options for acute heart failure syndromes: current treatments and unmet needs

Nieminen, M. S. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui009 · Cited by 7

Is echocardiography a valid tool to screen for left ventricular systolic dysfunction in chronic survivors of acute myocardial infarction? A comparison with radionuclide ventriculography

Galasko, G. I. W., Basu, S., Lahiri, A., & Senior, R. (2004) · Heart · doi:10.1136/hrt.2003.027425 · Cited by 7

Can new pulmonary gas exchange parameters contribute to evaluation of pulmonary congestion in left-sided heart failure?

Moesgaard, J., Kristensen, J. H., Malczynski, J., Holst‐Hansen, C., Rees, S. E., Murley, D., Andreassen, S., Frøkjær, J. B., & Toft, E. S. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70042-x · Cited by 5

Prescription in patients with chronic heart failure and multimorbidity attended in primary care.

Capell, E. F., Verdú-Rotellar, J. M., Colet, J. C., Miralles, J. D., Hermosilla, E., Wensing, M., & Suñol, R. (2013) · PubMed · Cited by 5

Natriuretic peptides for heart failure screening in nursing homes: a systematic review

Homar, V., Miroševič, Š., Švab, I., & Lainščak, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09944-w · Cited by 5

Treatment Of Heart Failure In A Teaching Hospital In Ghana, West Africa

(2007) · The Internet Journal of Third World Medicine · doi:10.5580/17c2 · Cited by 4

Carvedilol in the treatment of elderly patients with chronic heart failure

Witte, K. K. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1044 · Cited by 4

Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use

Bourgault, C., Elstein, E., Baltzan, M., LeLorier, J., & Suissa, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.595 · Cited by 4

New treatments for heart failure and exercise capacity

Solal, A. C., & Beauvais, F. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2374 · Cited by 1

Exercise Tolerance as a Guide to Therapeutic Efficacy for Heart Failure

Cohn, J. N. (1999) · Circulation · doi:10.1161/01.cir.100.22.2208 · Cited by 3

The treatment of heart failure—what next?

Davies, R. L., & Sheridan, D. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb04181.x · Cited by 3

Improving exercise capacity and quality of life using non‐invasive heart failure treatments: evidence from clinical trials

von Haehling, S., Arzt, M. E., Doehner, W., Edelmann, F., Evertz, R., Ebner, N., Herrmann‐Lingen, C., Garfias‐Veitl, T., Koziolek, M. J., Noutsias, M., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1838 · Cited by 119

Exercise Capacity in Chronic Heart Failure

Mentzer, G. G., & Auseon, A. J. (2012) · US Cardiology Review · doi:10.15420/usc.2012.9.1.57 · Cited by 2